These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 14612401)

  • 1. Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth.
    Fu M; Rao M; Wang C; Sakamaki T; Wang J; Di Vizio D; Zhang X; Albanese C; Balk S; Chang C; Fan S; Rosen E; Palvimo JJ; Jänne OA; Muratoglu S; Avantaggiati ML; Pestell RG
    Mol Cell Biol; 2003 Dec; 23(23):8563-75. PubMed ID: 14612401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function.
    Fu M; Wang C; Wang J; Zhang X; Sakamaki T; Yeung YG; Chang C; Hopp T; Fuqua SA; Jaffray E; Hay RT; Palvimo JJ; Jänne OA; Pestell RG
    Mol Cell Biol; 2002 May; 22(10):3373-88. PubMed ID: 11971970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity.
    Fu M; Rao M; Wu K; Wang C; Zhang X; Hessien M; Yeung YG; Gioeli D; Weber MJ; Pestell RG
    J Biol Chem; 2004 Jul; 279(28):29436-49. PubMed ID: 15123687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation.
    Fu M; Wang C; Reutens AT; Wang J; Angeletti RH; Siconolfi-Baez L; Ogryzko V; Avantaggiati ML; Pestell RG
    J Biol Chem; 2000 Jul; 275(27):20853-60. PubMed ID: 10779504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
    Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
    Kang Z; Jänne OA; Palvimo JJ
    Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor signaling: mechanism of interleukin-6 inhibition.
    Jia L; Choong CS; Ricciardelli C; Kim J; Tilley WD; Coetzee GA
    Cancer Res; 2004 Apr; 64(7):2619-26. PubMed ID: 15059919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
    Yoon HG; Wong J
    Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor.
    Trtková K; Pašková L; Matiješčuková N; Kolář Z
    Cancer Biomark; 2010; 7(2):79-90. PubMed ID: 21178266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer.
    Ai J; Wang Y; Dar JA; Liu J; Liu L; Nelson JB; Wang Z
    Mol Endocrinol; 2009 Dec; 23(12):1963-72. PubMed ID: 19855091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylation of androgen receptor by ARD1 promotes dissociation from HSP90 complex and prostate tumorigenesis.
    DePaolo JS; Wang Z; Guo J; Zhang G; Qian C; Zhang H; Zabaleta J; Liu W
    Oncotarget; 2016 Nov; 7(44):71417-71428. PubMed ID: 27659526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of AR to SMRT/N-CoR complex and its co-operation with PSA promoter in prostate cancer cells treated with natural histone deacetylase inhibitor NaB.
    Trtkova K; Paskova L; Matijescukova N; Strnad M; Kolar Z
    Neoplasma; 2010; 57(5):406-14. PubMed ID: 20568894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of androgen receptor transcriptional activity by inhibition of histone deacetylation--rescue of transcriptionally compromised mutants.
    Korkmaz CG; Frønsdal K; Zhang Y; Lorenzo PI; Saatcioglu F
    J Endocrinol; 2004 Sep; 182(3):377-89. PubMed ID: 15350180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells.
    Kikuchi M; Okumura F; Tsukiyama T; Watanabe M; Miyajima N; Tanaka J; Imamura M; Hatakeyama S
    Biochim Biophys Acta; 2009 Dec; 1793(12):1828-36. PubMed ID: 19909775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth.
    Wu K; Katiyar S; Witkiewicz A; Li A; McCue P; Song LN; Tian L; Jin M; Pestell RG
    Cancer Res; 2009 Apr; 69(8):3347-55. PubMed ID: 19351840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth.
    Daniels G; Li Y; Gellert LL; Zhou A; Melamed J; Wu X; Zhang X; Zhang D; Meruelo D; Logan SK; Basch R; Lee P
    Endocr Relat Cancer; 2014 Feb; 21(1):127-42. PubMed ID: 24243687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor.
    Cheng S; Brzostek S; Lee SR; Hollenberg AN; Balk SP
    Mol Endocrinol; 2002 Jul; 16(7):1492-501. PubMed ID: 12089345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procyanidin B3, an inhibitor of histone acetyltransferase, enhances the action of antagonist for prostate cancer cells via inhibition of p300-dependent acetylation of androgen receptor.
    Choi KC; Park S; Lim BJ; Seong AR; Lee YH; Shiota M; Yokomizo A; Naito S; Na Y; Yoon HG
    Biochem J; 2011 Jan; 433(1):235-44. PubMed ID: 20955177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer.
    Welsbie DS; Xu J; Chen Y; Borsu L; Scher HI; Rosen N; Sawyers CL
    Cancer Res; 2009 Feb; 69(3):958-66. PubMed ID: 19176386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.